{"doc_id": "pmid:12345", "sentence_id": "pmid:12345:abstract:0", "product_a": "metformin", "product_a_alias": "metformin", "product_b": "insulin", "product_b_alias": "insulin", "sentence_text": "Metformin combined with insulin improved glycemic control with fewer adverse events.", "publication_date": "2022-05-11", "journal": "Diabetes Care", "section": "abstract", "sent_index": 0, "count": 2, "recency_weight": 0.9, "study_type": "randomized controlled trial", "study_type_weight": 1.5, "combined_weight": 1.35, "evidence_weight": 2.7, "labels": ["improves", "comparative"], "matched_terms": "Metformin combined with insulin", "sentiment_label": "positive", "sentiment_score": 0.22, "sentiment_model": "lexicon", "sentiment_inference_ts": "2024-01-10T12:00:00Z", "confidence_breakdown": {"recency_weight": 0.9, "study_type": "randomized controlled trial", "study_type_weight": 1.5, "mention_count": 2, "combined_weight": 1.35, "final_confidence": 2.7}}
{"doc_id": "pmid:67890", "sentence_id": "pmid:67890:results:2", "product_a": "semaglutide", "product_a_alias": "Ozempic", "product_b": "liraglutide", "product_b_alias": "Victoza", "sentence_text": "Semaglutide showed non-inferior weight reduction compared to liraglutide over 24 weeks.", "publication_date": "2022-08-02", "journal": "Lancet", "section": "results", "sent_index": 2, "count": 1, "recency_weight": 0.85, "study_type": "clinical trial", "study_type_weight": 1.2, "combined_weight": 1.02, "evidence_weight": 1.02, "labels": ["non-inferior", "comparative"], "matched_terms": "Semaglutide ... liraglutide", "sentiment_label": "neutral", "sentiment_score": 0.0, "sentiment_model": "lexicon", "sentiment_inference_ts": "2024-01-10T12:00:00Z", "confidence_breakdown": {"recency_weight": 0.85, "study_type": "clinical trial", "study_type_weight": 1.2, "mention_count": 1, "combined_weight": 1.02, "final_confidence": 1.02}}
